Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0393754 (
HSA
)
2,996
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
62Cu-Labeling of human serum albumin-dithiosemicarbazone (HSA-DTS) conjugate was performed using a newly developed 62Zn/62Cu generator system.
HSA
-
DTS
was easily labeled with 62Cu, by simple mixing with 62Cu-generator eluate. In vivo blood clearance of 62Cu-
HSA
-
DTS
was similar to 131I-
HSA
, indicating the high applicability of 62Cu-
HSA
-
DTS
as a method for plasma volume measurement. In a positron emission tomography study of a dog, a clear plasma pool image of the head region was obtained.
...
PMID:62Cu-labeling of human serum albumin-dithiosemicarbazone (HSA-DTS) conjugate for regional plasma volume measurement: application of new 62Zn/62Cu generator system. 226 94
62Cu(T1/2 = 9.8 min) is a generator-produced positron-emitting radionuclide with a half-life amenable to blood-pool imaging with PET. Three bifunctional chelates [cyclic anhydride of diethylenetriaminepentaacetic acid (cDTPAA), 6-bromoacetamidobenzyl-1,4,8,11-tetraazacyclotetradecane-N,N ',N", N"'-tetraacetic acid (BAT), and p-carboxyethylphenylglyoxal-bis-(4N-methyl-thiosemicarbazone (CE-
DTS
)] were conjugated to
HSA
and labeled with 67Cu. The labeling efficiency of 67Cu-
DTS
-
HSA
was > 90%, whereas the labeling yields of 67Cu-DTPA-
HSA
and 67Cu-benzyl-TETA-
HSA
were less than 70%. Blood clearance and biodistribution of these three 67Cu-labeled conjugates were determined in rats. Of the three 67Cu-labeled bifunctional chelate-
HSA
conjugates, 67Cu-benzyl-TETA-
HSA
remained in the blood pool the longest, achieving stable blood levels at times longer than 24 h post-injection. The 67Cu radioactivity cleared the blood within 60 min post-injection of 67Cu-
DTS
-
HSA
, and within 10 min after administration of 67Cu-DTPA-
HSA
, indicating the dissociation of Cu2+ from these conjugates. Copper-labeled
DTS
-
HSA
achieved stable blood concentrations for at least 30 min post-injection and was therefore evaluated as a vascular imaging agent.
DTS
-
HSA
and benzyl-TETA-
HSA
were labeled with 62Cu and administered to a dog for blood-pool imaging using PET. Images were nearly identical to an image taken after administration of C15O. Because of the high labeling efficiency,
DTS
-
HSA
can be labeled with 62Cu without purification, making it more practical than 62Cu-benzyl-TETA-
HSA
as a blood-pool imaging agent.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging. 850 88